Insider Transactions Reported by 12 Insiders of LAVA Therapeutics NV

Location
Utrecht

Insiders trading volume in the past year

LAVA Therapeutics NV executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Cooperatieve Gilde Healthcare IV U.A. 10%+ Owner $2,843,760 -$3,379,338 -54% 16 Oct 2025
STEPHEN A. HURLY Chief Executive Officer, Director $0 13 Nov 2025
Fred M. Powell Chief Financial Officer $0 13 Nov 2025
Versant Venture Capital VI, L.P. 10%+ Owner $0 -$6,571,090 -100% 19 Sep 2025
Kapil Dhingra Director $0 13 Nov 2025
KAREN J. WILSON Director $0 13 Nov 2025
Mary E. Wadlinger Director 13 Nov 2025
Peter A. Kiener Director 13 Nov 2025
James Noble Director 13 Nov 2025
Christy J. Oliger Director 13 Nov 2025
Charles Q. Morris Chief Medical Officer 13 Feb 2025
Backstrom Jay T. Director 13 Nov 2025

Recent Insider Transactions by Companies or Individuals for LAVA Therapeutics NV

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Fred M. Powell LVTX Common Shares Disposed to Issuer -100% -65,000 0 13 Nov 2025 Direct
Fred M. Powell LVTX Share Options (Right to Buy) Disposed to Issuer -100% -124,700 0 13 Nov 2025 Direct
Mary E. Wadlinger LVTX Share Options (Right to Buy) Disposed to Issuer -100% -33,390 0 13 Nov 2025 Direct
Christy J. Oliger LVTX Share Options (Right to Buy) Disposed to Issuer -100% -33,390 0 13 Nov 2025 Direct
James Noble LVTX Share Options (Right to Buy) Disposed to Issuer -100% -33,390 0 13 Nov 2025 Direct
Peter A. Kiener LVTX Share Options (Right to Buy) Disposed to Issuer -100% -33,390 0 13 Nov 2025 Direct
Backstrom Jay T. LVTX Share Options (Right to Buy) Disposed to Issuer -100% -33,390 0 13 Nov 2025 Direct
KAREN J. WILSON LVTX Common Shares Disposed to Issuer -100% -10,000 0 13 Nov 2025 Direct
KAREN J. WILSON LVTX Share Options (Right to Buy) Disposed to Issuer -100% -33,390 0 13 Nov 2025 Direct
Kapil Dhingra LVTX Common Shares Disposed to Issuer -100% -30,000 0 13 Nov 2025 Direct
Kapil Dhingra LVTX Share Options (Right to Buy) Disposed to Issuer -100% -33,390 0 13 Nov 2025 Direct
STEPHEN A. HURLY LVTX Common Shares Disposed to Issuer -100% -5,000 0 13 Nov 2025 Direct
STEPHEN A. HURLY LVTX Share Options (Right to Buy) Disposed to Issuer -100% -335,100 0 13 Nov 2025 Direct
Gilde Healthcare IV U.A. Cooperatieve LVTX Common Shares Sale -28.6% $1,736,263 $1.47 -1,181,131 2,947,781 17 Oct 2025 Direct
Gilde Healthcare IV U.A. Cooperatieve LVTX Common Shares Sale -14.3% $1,028,456 $1.49 -690,239 4,128,912 16 Oct 2025 Direct
Gilde Healthcare IV U.A. Cooperatieve LVTX Common Shares Sale -4.33% $343,285 $1.51 -227,341 5,019,151 14 Oct 2025 Direct
Gilde Healthcare IV U.A. Cooperatieve LVTX Common Shares Sale -0.9% $73,436 $1.54 -47,686 5,246,492 13 Oct 2025 Direct
Gilde Healthcare IV U.A. Cooperatieve LVTX Common Shares Sale -0.93% $77,297 $1.55 -49,869 5,294,178 10 Oct 2025 Direct
Gilde Healthcare IV U.A. Cooperatieve LVTX Common Shares Sale -0.89% $75,144 $1.56 -48,169 5,344,047 09 Oct 2025 Direct
Gilde Healthcare IV U.A. Cooperatieve LVTX Common Shares Sale -0.53% $45,458 $1.57 -28,954 5,392,216 08 Oct 2025 Direct
Versant Venture Capital VI, L.P. LVTX Common Stock Sale -100% $746,764 $1.40 -532,870 0 19 Sep 2025 See Footnote
Versant Venture Capital VI, L.P. LVTX Common Stock Sale -100% $3,322,065 $1.40 -2,370,533 0 19 Sep 2025 Direct
Versant Venture Capital VI, L.P. LVTX Common Stock Sale -30% $329,871 $1.44 -228,791 532,870 18 Sep 2025 See Footnote
Versant Venture Capital VI, L.P. LVTX Common Stock Sale -13.4% $527,859 $1.44 -366,111 2,370,533 18 Sep 2025 Direct
Versant Venture Capital VI, L.P. LVTX Common Stock Sale -22.9% $337,640 $1.49 -226,726 761,661 17 Sep 2025 See Footnote
Versant Venture Capital VI, L.P. LVTX Common Stock Sale -11.7% $540,291 $1.49 -362,806 2,736,644 17 Sep 2025 Direct
Versant Venture Capital VI, L.P. LVTX Common Stock Sale -16.3% $294,824 $1.53 -192,293 988,387 16 Sep 2025 See Footnote
Versant Venture Capital VI, L.P. LVTX Common Stock Sale -9.03% $471,776 $1.53 -307,707 3,099,450 16 Sep 2025 Direct
KAREN J. WILSON LVTX Common Shares (Right to Buy) Award 33,390 33,390 13 Feb 2025 Direct
Mary E. Wadlinger LVTX Common Shares (Right to Buy) Award 33,390 33,390 13 Feb 2025 Direct
James Noble LVTX Common Shares (Right to Buy) Award 33,390 33,390 13 Feb 2025 Direct
Peter A. Kiener LVTX Common Shares (Right to Buy) Award 33,390 33,390 13 Feb 2025 Direct
Backstrom Jay T. LVTX Common Shares (Right to Buy) Award 33,390 33,390 13 Feb 2025 Direct
Kapil Dhingra LVTX Common Shares (Right to Buy) Award 33,390 33,390 13 Feb 2025 Direct
Fred M. Powell LVTX Share Options (Right to Buy) Award 124,700 124,700 13 Feb 2025 Direct
Charles Q. Morris LVTX Share Options (Right to Buy) Award 130,850 130,850 13 Feb 2025 Direct
Christy J. Oliger LVTX Common Shares (Right to Buy) Award 33,390 33,390 13 Feb 2025 Direct
STEPHEN A. HURLY LVTX Share Options (Right to Buy) Award 335,100 335,100 13 Feb 2025 Direct
Gilde Healthcare IV U.A. Cooperatieve LVTX Common Shares Sale -33.9% $1,460,000 $1.46 -1,000,000 1,947,781 20 Oct 2015 Direct
Gilde Healthcare IV U.A. Cooperatieve LVTX Common Shares Sale -3.98% -200,000 4,819,151 15 Oct 2015 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.